Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib induction study in moderately to severely active ulcerative colitis
RBR-3q8j43Phase 3Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in autoimmune colitis comparing Tofacitinib 10 mg twice daily with Placebo twice daily (2 arms). Started Oct 2011; status: recruiting.
02
Drugs
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on RBR-3q8j43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3q8j43.